Literature DB >> 21464285

Structures of p63 DNA binding domain in complexes with half-site and with spacer-containing full response elements.

Chen Chen1, Natalia Gorlatova, Zvi Kelman, Osnat Herzberg.   

Abstract

Transcription factor p63, a p53 family member, plays a role in epithelial cell development, cell cycle arrest, apoptosis, and tumorigenesis. Point mutations, primarily in the DNA binding domain (p63DBD), lead to malformation syndromes. To gain insight into differences between p63 and p53 and the impact of mutations on the structure, we have determined two crystal structures of p63DBD in complex with A/T-rich response elements. One complex contains a 10-bp DNA half-site response element (5'AAACATGTTT3') and the other contains a 22-bp DNA full response element with a 2-bp spacer between two half-sites (5'AAACATGTTTTAAAACATGTTT3'). In both structures, each half-site binds a p63DBD dimer. The two p63DBD dimers do not interact in the presence of the DNA spacer, whereas they interact with one another in the p63DBD/10-bp complex where the DNA simulates a full response element by packing end-to-end. A unique dimer-dimer interaction involves a variable loop region, which differs in length and sequence from the counterpart loop of p53DBD. The DNA trajectories in both structures assume superhelical conformations. Surface plasmon resonance studies of p63DBD/DNA binding yielded K(d) = 11.7 μM for a continuous full response element, whereas binding was undetectable with the 22-bp DNA, suggesting an important contribution of a p63DBD interdimer interface to binding and establishing that p63DBD affinity to the response element is approximately 1,000-fold lower than that of p53DBD. Analyses of the structural consequences of p63DBD mutations that cause developmental defects show that, although some mutations affect DNA binding directly, the majority affects protein stability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464285      PMCID: PMC3080992          DOI: 10.1073/pnas.1013657108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

3.  Loss of protein structure stability as a major causative factor in monogenic disease.

Authors:  Peng Yue; Zhaolong Li; John Moult
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

4.  p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.

Authors:  James W Rocco; Chee-Onn Leong; Nicolas Kuperwasser; Maurice Phillip DeYoung; Leif W Ellisen
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 31.743

5.  GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner.

Authors:  Wensheng Yan; Xinbin Chen
Journal:  J Biol Chem       Date:  2006-01-30       Impact factor: 5.157

6.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

Authors:  A Yang; M Kaghad; Y Wang; E Gillett; M D Fleming; V Dötsch; N C Andrews; D Caput; F McKeon
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

7.  Importance of DNA stiffness in protein-DNA binding specificity.

Authors:  M E Hogan; R H Austin
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

8.  Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.

Authors:  P Balagurumoorthy; H Sakamoto; M S Lewis; N Zambrano; G M Clore; A M Gronenborn; E Appella; R E Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

Review 9.  p63: oncogene or tumor suppressor?

Authors:  Alea A Mills
Journal:  Curr Opin Genet Dev       Date:  2005-12-15       Impact factor: 5.578

10.  Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets.

Authors:  Itai Beno; Karin Rosenthal; Michael Levitine; Lihi Shaulov; Tali E Haran
Journal:  Nucleic Acids Res       Date:  2010-11-10       Impact factor: 16.971

View more
  25 in total

1.  Pliable DNA conformation of response elements bound to transcription factor p63.

Authors:  Chen Chen; Natalia Gorlatova; Osnat Herzberg
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

2.  Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.

Authors:  Abdul S Ethayathulla; Pui-Wah Tse; Paola Monti; Sonha Nguyen; Alberto Inga; Gilberto Fronza; Hector Viadiu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.

Authors:  Abdul S Ethayathulla; H Thien Nguyen; Hector Viadiu
Journal:  J Biol Chem       Date:  2012-12-14       Impact factor: 5.157

Review 4.  Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer.

Authors:  Adam R Blanden; Xin Yu; Stewart N Loh; Arnold J Levine; Darren R Carpizo
Journal:  Drug Discov Today       Date:  2015-07-20       Impact factor: 7.851

5.  Designed Ankyrin Repeat Proteins as a tool box for analyzing p63.

Authors:  Alexander Strubel; Philipp Münick; Apirat Chaikuad; Birgit Dreier; Jonas Schaefer; Jakob Gebel; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Stefan Knapp; Andreas Plückthun; Volker Dötsch
Journal:  Cell Death Differ       Date:  2022-06-18       Impact factor: 15.828

Review 6.  p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis.

Authors:  Xiaohua Su; Deepavali Chakravarti; Elsa R Flores
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

7.  Requirement of zinc transporter ZIP10 for epidermal development: Implication of the ZIP10-p63 axis in epithelial homeostasis.

Authors:  Bum-Ho Bin; Jinhyuk Bhin; Mikiro Takaishi; Koh-Ei Toyoshima; Saeko Kawamata; Kana Ito; Takafumi Hara; Takashi Watanabe; Tarou Irié; Teruhisa Takagishi; Su-Hyon Lee; Haeng-Sun Jung; Sangchul Rho; Juyeon Seo; Dong-Hwa Choi; Daehee Hwang; Haruhiko Koseki; Osamu Ohara; Shigetoshi Sano; Takashi Tsuji; Kenji Mishima; Toshiyuki Fukada
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

8.  Structural basis for ASPP2 recognition by the tumor suppressor p73.

Authors:  Peter Canning; Frank von Delft; Alex N Bullock
Journal:  J Mol Biol       Date:  2012-08-20       Impact factor: 5.469

9.  Analysis of large phenotypic variability of EEC and SHFM4 syndromes caused by K193E mutation of the TP63 gene.

Authors:  Jianhua Wei; Yang Xue; Lian Wu; Jie Ma; Xiuli Yi; Junrui Zhang; Bin Lu; Chunying Li; Dashuang Shi; Songtao Shi; Xinghua Feng; Tao Cai
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.

Authors:  Yari Ciribilli; Paola Monti; Alessandra Bisio; H Thien Nguyen; Abdul S Ethayathulla; Ana Ramos; Giorgia Foggetti; Paola Menichini; Daniel Menendez; Michael A Resnick; Hector Viadiu; Gilberto Fronza; Alberto Inga
Journal:  Nucleic Acids Res       Date:  2013-07-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.